{"id":"fengshigutong-capsule-plus-imrecoxib","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Abdominal pain"},{"rate":null,"effect":"Dyspepsia"},{"rate":null,"effect":"Cardiovascular events (COX-2 inhibitor class risk)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Fengshigutong Capsule is a traditional Chinese herbal formulation designed to address wind-damp-heat patterns associated with joint pain and inflammation. Imrecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor that reduces prostaglandin production and inflammatory mediators. The combination leverages both traditional herbal anti-inflammatory mechanisms and modern selective COX-2 inhibition for enhanced therapeutic effect in rheumatologic conditions.","oneSentence":"This combination product combines traditional Chinese medicine (Fengshigutong) with Imrecoxib, a selective COX-2 inhibitor, to reduce inflammation and pain in joint and musculoskeletal conditions.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:46:18.735Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Osteoarthritis"},{"name":"Joint pain and inflammation"}]},"trialDetails":[{"nctId":"NCT03932006","phase":"PHASE4","title":"A Multicenter，Double-Blind and Randomized Controlled Trial of Fengshigutong Capsule in the Treatment of Ankylosing Spondylitis","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2016-06-30","conditions":"Ankylosing Spondylitis","enrollment":180}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Fengshigutong Capsule plus Imrecoxib","genericName":"Fengshigutong Capsule plus Imrecoxib","companyName":"Sun Yat-sen University","companyId":"sun-yat-sen-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination product combines traditional Chinese medicine (Fengshigutong) with Imrecoxib, a selective COX-2 inhibitor, to reduce inflammation and pain in joint and musculoskeletal conditions. Used for Rheumatoid arthritis, Osteoarthritis, Joint pain and inflammation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}